Evidence map›Paper›PMID 21399645›Full record

ArticleNature biotechnology2011

Label-free quantification of membrane-ligand interactions using backscattering interferometry.

Michael M Baksh, Amanda K Kussrow, Mauro Mileni, M G Finn, Darryl J Bornhop

Abstract read
In one paragraph

Article in Nature biotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Revisiting peptidoglycan sensing: interactions with host immunity and beyond.Chemical communications (Cambridge, England) · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael M BakshDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Amanda K Kussrow
Mauro Mileni
M G Finn
Darryl J Bornhop
Scripps Research Institute · USVanderbilt University · US

Funding

JCSG Center:Innovative Membrane Protein Technology (RMI)P50GM073197 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI STEVENS, RAYMOND C · 2004 to 2013
$26.8M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
National cooperative drug discovery groups for treatment of mood disorderU01MH069062 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARKOU, ATHINA · 2003 to 2007
$3.4M
Interferometric Nano-sensing for Biochemical AnalysisR01EB003537 · NIBIB · VANDERBILT UNIVERSITY · PI BORNHOP, DARRYL J. · 2005 to 2008
$891k
NIBIB NIH HHS R01 EB003537NIGMS NIH HHS GM073197NIGMS NIH HHS P50 GM073197NIGMS NIH HHS T32 GM065086NIMH NIH HHS U01 MH069062
6 · The paper itself

Abstract

Although membrane proteins are ubiquitous within all living organisms and represent the majority of drug targets, a general method for direct, label-free measurement of ligand binding to native membranes has not been reported. Here we show that backscattering interferometry (BSI) can accurately quantify ligand-receptor binding affinities in a variety of membrane environments. By detecting minute changes in the refractive index of a solution, BSI allows binding interactions of proteins with their ligands to be measured at picomolar concentrations. Equilibrium binding constants in the micromolar to picomolar range were obtained for small- and large-molecule interactions in both synthetic and cell-derived membranes without the use of labels or supporting substrates. The simple and low-cost hardware, high sensitivity and label-free nature of BSI should make it readily applicable to the study of many membrane-associated proteins of biochemical and pharmacological interest.

Indexed as

AmidohydrolasesCholera ToxinFatty Acid Amide HydrolasesG(M1) GangliosideHumansInterferometryKineticsLigandsMembrane ProteinsMicroscopy, FluorescenceProtein BindingReceptors, CXCR4Receptors, GABA-BRefractometryAmidohydrolasesCholera ToxinFatty Acid Amide HydrolasesG(M1) GangliosideLigandsMembrane ProteinsReceptors, CXCR4Receptors, GABA-B

Identifiers

PMID21399645
PMCPMC3246389
OpenAlexW2014556797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.